Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Chronimed Schedules Third Quarter Financial Results Release and Conference Call.


Business Editors & Health/Medical Writers

MINNEAPOLIS--(BUSINESS WIRE)--April 24, 2002

Chronimed Inc. (Nasdaq:CHMD CHMD Change Mode Command ), will release financial results for its third quarter ended March 29, 2002 after market close on Tuesday, April 30, 2002. Chronimed will host a conference call at 9:00 AM CDT CDT
abbr.
Central Daylight Time


CDT Central Daylight Time

CDT n abbr (US) (= Central Daylight Time) → hora de verano del centro;
(BRIT
 on Wednesday, May 1, 2002 featuring remarks by chairman and chief executive officer, Henry Blissenbach and chief financial officer, Greg Keane.

A live broadcast of the conference call can be heard by dialing 212-896-6010 or via the Company's web site at www.chronimed.com. A replay of the call will be made available starting at 11:00 AM CDT on May 1, 2002 through 11:00 AM CDT on May 2, 2002 and can be accessed by dialing 800-633-8284 or 858-812-6440 access number 20552994. A replay of the conference call will also be made available at www.chronimed.com.

About Chronimed

Chronimed Inc. is a disease-focused drug distribution company serving the prescription drug prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug,  needs of people with chronic health conditions. The Company distributes pharmaceuticals and provides specialized patient management services nationwide for people with chronic conditions such as HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome , organ transplant organ transplant: see transplantation, medical.  and diseases treated with biotech injectable in·ject·a·ble
adj.
Capable of being injected. Used of a drug.

n.
A drug or medicine that can be injected.
 medications. Chronimed works directly with patients, providers, payors, manufacturers and wholesalers to improve clinical and cost-of-care outcomes. Chronimed's web site address is www.chronimed.com.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Apr 24, 2002
Words:219
Previous Article:Jane L. Lundquist Named President and Chief Operating Officer of Cambridgeport Bank.
Next Article:Milacron Elects Four Directors.
Topics:



Related Articles
Chronimed Sets Fiscal Second Quarter Financial Release Date and Conference Call.
Chronimed Reports Fiscal 2002 Third Quarter Results; Reports Record Revenue; Earnings Of $0.07 Per Share.
Chronimed Sets Fiscal 2002 Fourth Quarter and Full Year Financial Results Release Date and Conference Call.
Chronimed Sets Fiscal 2003 First Quarter Financial Results Release Date and Conference Call.
Chronimed Sets Fiscal 2003 Second Quarter Financial Results Release Date and Conference Call.
Chronimed Sets Fiscal 2003 Third Quarter Financial Results Release Date and Conference Call.
Chronimed Reports Fiscal 2003 Third Quarter Results; Reports Record Quarterly Revenue and Provides Guidance for Fiscal Year 2004.
Chronimed Sets Fiscal 2003 Fourth Quarter and Full Year Financial Results Release Date and Conference Call.
Chronimed Sets Fiscal 2004 Third Quarter and Nine Month Financial Results Release Date and Conference Call.
Chronimed Reports Fiscal 2004 Third Quarter Results; Raises Fiscal 2004 Financial Guidance; Comments on Aetna Contract.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles